Jacqueline Burrows

Jacqueline Burrows

UNVERIFIED PROFILE

Are you Jacqueline Burrows?   Register this Author

Register author
Jacqueline Burrows

Jacqueline Burrows

Publications by authors named "Jacqueline Burrows"

Are you Jacqueline Burrows?   Register this Author

26Publications

384Reads

5Profile Views

Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis.

Clin Transl Immunology 2017 Jan 20;6(1):e126. Epub 2017 Jan 20.

School of Medicine, The University of Queensland, Brisbane, Queensland, Australia; Cellular ImmunoIogy Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/cti.2016.87DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292561PMC
January 2017

T Cell Cross-Reactivity between a Highly Immunogenic EBV Epitope and a Self-Peptide Naturally Presented by HLA-B*18:01+ Cells.

J Immunol 2015 May 8;194(10):4668-75. Epub 2015 Apr 8.

QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia; School of Medicine, University of Queensland, Brisbane, Queensland 4072, Australia;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1500233DOI Listing
May 2015

T cell epitope clustering in the highly immunogenic BZLF1 antigen of Epstein-Barr virus.

J Virol 2015 Jan 29;89(1):703-12. Epub 2014 Oct 29.

Cellular Immunology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia School of Medicine, The University of Queensland, Brisbane, Australia

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.02642-14DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301143PMC
January 2015

HLA peptide length preferences control CD8+ T cell responses.

J Immunol 2013 Jul 7;191(2):561-71. Epub 2013 Jun 7.

Centre for Immunotherapy and Vaccine Development, Queensland Institute of Medical Research, Brisbane, Queensland 4029, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1300292DOI Listing
July 2013

The impact of a large and frequent deletion in the human TCR β locus on antiviral immunity.

J Immunol 2012 Mar 8;188(6):2742-8. Epub 2012 Feb 8.

Australian Centre for Vaccine Development, Queensland Institute of Medical Research, Brisbane, Queensland 4029, Australia.

View Article

Download full-text PDF

Source
http://www.jimmunol.org/cgi/doi/10.4049/jimmunol.1102675
Publisher Site
http://dx.doi.org/10.4049/jimmunol.1102675DOI Listing
March 2012

The peptide length specificity of some HLA class I alleles is very broad and includes peptides of up to 25 amino acids in length.

Mol Immunol 2009 May 20;46(8-9):1911-7. Epub 2009 Jan 20.

Queensland Institute of Medical Research and Australian Centre for Vaccine Development, Herston, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molimm.2008.12.003DOI Listing
May 2009

Widespread sequence variation in Epstein-Barr virus nuclear antigen 1 influences the antiviral T cell response.

J Infect Dis 2008 Jun;197(11):1594-7

Queensland Institute of Medical Research and Australian Centre for Vaccine Development, University of Queensland, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/587848DOI Listing
June 2008

Preferential binding of unusually long peptides to MHC class I and its influence on the selection of target peptides for T cell recognition.

Mol Immunol 2008 Mar 5;45(6):1818-24. Epub 2007 Nov 5.

Queensland Institute of Medical Research and Australian Centre for Vaccine Development, 300 Herston Road, Herston 4029, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molimm.2007.09.026DOI Listing
March 2008

The impact of HLA-B micropolymorphism outside primary peptide anchor pockets on the CTL response to CMV.

Eur J Immunol 2007 Apr;37(4):946-53

Division of Infectious Diseases and Immunology, Queensland Institute of Medical Research, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.200636588DOI Listing
April 2007

Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load.

J Infect Dis 2006 Mar 30;193(5):664-71. Epub 2006 Jan 30.

School of Medical Sciences, Inflammatory Diseases Research Unit, University of New South Wales, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/500248DOI Listing
March 2006

Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.

Clin Cancer Res 2006 Jan;12(2):460-4

Tumour Immunology Laboratory, Division of Infectious Diseases and Immunology, Queensland Institute of Medical Research, Department of Haematology, Princess Alexandra Hospital, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-05-2008DOI Listing
January 2006

T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide.

Nat Immunol 2005 Nov 25;6(11):1114-22. Epub 2005 Sep 25.

The Protein Crystallography Unit, Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, Victoria 3800, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ni1257DOI Listing
November 2005

The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation.

J Exp Med 2005 Nov;202(9):1249-60

The Protein Crystallography Unit, Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20050864DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213230PMC
November 2005

CTL recognition of a bulged viral peptide involves biased TCR selection.

J Immunol 2005 Sep;175(6):3826-34

Cellular Immunology Laboratory, Queensland Institute of Medical Research, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.175.6.3826DOI Listing
September 2005

Contemporaneous fluctuations in T cell responses to persistent herpes virus infections.

Eur J Immunol 2005 Jan;35(1):139-49

Tumour Immunology Laboratory and Co-operative Centre for Vaccine Technology, Queensland Institute of Medical Research, Department of Molecular and Cellular Pathology, University of Queensland, Brisbane 4006, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.200425548DOI Listing
January 2005

Selection pressure-driven evolution of the Epstein-Barr virus-encoded oncogene LMP1 in virus isolates from Southeast Asia.

J Virol 2004 Jul;78(13):7131-7

Tumour Immunology Laboratory, Division of Infectious Diseases and Immunology, Queensland Institute of Medical Research, and Department of Molecular and Cellular Pathology, University of Queensland, Brisbane, Australia 4029.

View Article

Download full-text PDF

Source
http://jvi.asm.org/cgi/doi/10.1128/JVI.78.13.7131-7137.2004
Publisher Site
http://dx.doi.org/10.1128/JVI.78.13.7131-7137.2004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC421669PMC
July 2004

Ex vivo analysis of T-cell responses to Epstein-Barr virus-encoded oncogene latent membrane protein 1 reveals highly conserved epitope sequences in virus isolates from diverse geographic regions.

J Virol 2003 Jul;77(13):7401-10

Cooperative Research Centre for Vaccine Technology, Division of Infectious Diseases and Immunology, Queensland Institute of Medical Research, Department of Molecular and Cellular Pathology, University of Queensland, Brisbane, Australia 4029.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC164808PMC
http://dx.doi.org/10.1128/jvi.77.13.7401-7410.2003DOI Listing
July 2003

Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy.

Transplantation 2003 May;75(9):1556-60

The Cooperative Research Centre for Vaccine Technology, Division of Immunology and Infectious Diseases, The Queensland Institute of Medical Research and University of Queensland Joint Oncology Program, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.TP.0000058745.02123.6FDOI Listing
May 2003